Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03741192
What this trial is testing

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs

Who this might be right for
Epilepsy Intractable
Brain Sentinel 58
Not applicableLooking for participantsNCT06601153
What this trial is testing

Health Improvements by Understanding the Determinants of Residual Risk in Coronary Artery Disease and New Targets for Prevention and Treatment

Who this might be right for
Coronary Arterial Disease (CAD)
Fondazione Toscana Gabriele Monasterio 961
Early research (Phase 1)Study completedNCT04032301
What this trial is testing

Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans

Who this might be right for
Post-Traumatic Stress DisordersMajor Depressive Disorder
University of Minnesota 67
Very early researchUnknownNCT02587741
What this trial is testing

Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens

Who this might be right for
Diabetic Retinopathy
Third Affiliated Hospital, Sun Yat-Sen University 600
Not applicableLooking for participantsNCT04923828
What this trial is testing

Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections

Who this might be right for
Severe Infection
Children's Hospital of Fudan University 2,000
Testing effectiveness (Phase 2)Study completedNCT01936831
What this trial is testing

High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)

Who this might be right for
Tuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 282
Testing effectiveness (Phase 2)Study completedNCT00001339
What this trial is testing

Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection

Who this might be right for
Adrenal Cortical Carcinoma
National Cancer Institute (NCI) 42
Not applicableStudy completedNCT02886650
What this trial is testing

Impact of Thermocoagulation During Invasive EEG Monitoring in Children With Focal Drug-resistant Epilepsies

Who this might be right for
Epilepsy
Fondation Ophtalmologique Adolphe de Rothschild 100
Testing effectiveness (Phase 2)Ended earlyNCT03729596
What this trial is testing

MGC018 With or Without MGA012 in Advanced Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of Head and NeckTriple Negative Breast CancerMelanoma+3 more
MacroGenics 143
Not applicableUnknownNCT06035796
What this trial is testing

Performance Study of Targeted Sequencing Technology for VAP

Who this might be right for
VAP - Ventilator Associated Pneumonia
The First Hospital of Jilin University 150
Testing effectiveness (Phase 2)UnknownNCT05579184
What this trial is testing

[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, mCRPC
FutureChem 20
Large-scale testing (Phase 3)Study completedNCT05218655
What this trial is testing

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

Who this might be right for
Inherited Mitochondrial Disease
PTC Therapeutics 101
Testing effectiveness (Phase 2)Study completedNCT00126880
What this trial is testing

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Who this might be right for
HIV Infections
Avexa 52
Large-scale testing (Phase 3)Ended earlyNCT01455246
What this trial is testing

Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis

Who this might be right for
CirrhosisAscitesNosocomial Spontaneous Bacterial Peritonitis
University of Padova 32
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Not applicableStudy completedNCT02426047
What this trial is testing

Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy

Who this might be right for
EpilepsySeizureCatamenial Epilepsy+2 more
Johns Hopkins University 16
Large-scale testing (Phase 3)Looking for participantsNCT04188743
What this trial is testing

Decolonization of Gram-negative Multi-resistant Organisms (MDRO) with Donor Microbiota (FMT)

Who this might be right for
Resistance Bacterial
University Hospital, Ghent 150
Very early researchLooking for participantsNCT07095933
What this trial is testing

The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy

Who this might be right for
EpilepsyDrug Resistant
Xuanwu Hospital, Beijing 5
Testing effectiveness (Phase 2)Study completedNCT00755976
What this trial is testing

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Cancer Trials Ireland 32
Not applicableStudy completedNCT04147676
What this trial is testing

Evaluation of Centralised TB Assay Solutions

Who this might be right for
TuberculosisDrug-resistant Tuberculosis
Foundation for Innovative New Diagnostics, Switzerland 1,050
Next Page